Supplement to lower high lipoprotein(a) levels
Part of Hormones & metabolism clinical trials.
This trial tests whether a daily supplement can safely reduce high levels of lipoprotein(a), a type of fat in the blood linked to heart disease. Participation lasts about 12 weeks and involves regular check-ins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 69 years old
- Your lipoprotein(a) level is 90 mg/dL or higher (a blood test can confirm)
- You are not pregnant, planning to become pregnant, or breastfeeding
- You have no known heart disease or bleeding disorders
- You are willing to keep your diet and exercise routine stable during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This study tests if a medication called olpasiran can lower a type of fat in your blood called Lp(a), which is linked to heart problems. You take the medicine or a placebo and get a special heart scan to see changes in your arteries.
This Phase 2 trial tests whether 2-HOBA can improve how “good cholesterol” (HDL) works in people with familial hypercholesterolemia (FH). If HDL works better, it may help lower heart risk markers. You would need to meet several heart, health, and medication-related safety checks.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
This trial tests whether a natural compound called 2-HOBA can help women with lupus who also have mildly high blood pressure. It aims to improve blood vessel health and reduce inflammation.
This study tests an investigational medicine given by injection to lower Lp(a), a type of fat linked to heart disease. It may help people with high Lp(a) who already have heart problems or are at increased risk.
Hear when a new Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.